资讯

Clinical Trials Arena5 小时
Pasithea to commence Phase I/Ib trial of neurofibromatosis type 1 therapy
Pasithea has announced the commencement of a Phase I/Ib open-label trial of PAS-004 for treating adults with ...
Clinical Trials Arena5 小时
ADC Therapeutics ends development of ADCT-602 and unveils latest Zynlonta data
ADC Therapeutics has pulled the drug candidate from development, leaving it with one remaining clinical asset.
Clinical Trials Arena7 小时
Nuvig Therapeutics begins dosing in trial of NVG-2089 for CIDP
Nuvig Therapeutics has dosed the first subject in its Phase II INVGOR trial of NVG-2089 for individuals with CIDP.